Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
The New England Journal of Medicine
|
September 24, 2010
Fondaparinux for the treatment of superficial-vein thrombosis in the legs
Hervé Decousus, Paolo Prandoni, Patrick Mismetti, et al.
Respiratory Research
|
July 20, 2013
Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry
Laurent Bertoletti, Sara Quenet, Silvy Laporte, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2007
Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials
Jean-Yves Douillard, Silvy Laporte, Frank Fossella, et al.
Intensive Care Medicine
|
June 27, 2003
Prognostic factors in acute respiratory distress syndrome: a retrospective multivariate analysis including prone positioning in management strategy
Christophe Venet, Stephane Guyomarc'h, Juliette Pingat, et al.
Research and Practice in Thrombosis and Haemostasis
|
February 2, 2026
The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis
Céline Chapelle, Philippe Girard, Luis Jara-Palomares, et al.
The Lancet. Haematology
|
December 9, 2025
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Isabelle Mahé, Céline Chapelle, Philippe Girard, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 26, 2026
API-CAT Investigators' Decisions on Anticoagulation following Extended Treatment for Cancer VTE
Isabelle Mahé, Florent Happe, Manuel Monreal, et al.
BMJ Open
|
March 15, 2013
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials
Silvy Laporte, Pierre Squifflet, Noémie Baroux, et al.
Cancers
|
August 19, 2020
Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
Isabelle Mahé, Ludovic Plaisance, Céline Chapelle, et al.
Journal of Cancer Science and Clinical Therapeutics
|
May 11, 2023
Reasons Influencing Long-Term Anticoagulant Treatment Beyond 6 Months for Cancer-Associated Thrombosis in USCAT, A 432-Patient Retrospective Non-Interventional Study
Ludovic Plaisance, Céline Chapelle, Silvy Laporte, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
The New England Journal of Medicine
|
September 24, 2010
Fondaparinux for the treatment of superficial-vein thrombosis in the legs
Hervé Decousus, Paolo Prandoni, Patrick Mismetti, et al.
Respiratory Research
|
July 20, 2013
Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry
Laurent Bertoletti, Sara Quenet, Silvy Laporte, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2007
Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials
Jean-Yves Douillard, Silvy Laporte, Frank Fossella, et al.
Intensive Care Medicine
|
June 27, 2003
Prognostic factors in acute respiratory distress syndrome: a retrospective multivariate analysis including prone positioning in management strategy
Christophe Venet, Stephane Guyomarc'h, Juliette Pingat, et al.
Research and Practice in Thrombosis and Haemostasis
|
February 2, 2026
The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis
Céline Chapelle, Philippe Girard, Luis Jara-Palomares, et al.
The Lancet. Haematology
|
December 9, 2025
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Isabelle Mahé, Céline Chapelle, Philippe Girard, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 26, 2026
API-CAT Investigators' Decisions on Anticoagulation following Extended Treatment for Cancer VTE
Isabelle Mahé, Florent Happe, Manuel Monreal, et al.
BMJ Open
|
March 15, 2013
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials
Silvy Laporte, Pierre Squifflet, Noémie Baroux, et al.
Cancers
|
August 19, 2020
Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
Isabelle Mahé, Ludovic Plaisance, Céline Chapelle, et al.
Journal of Cancer Science and Clinical Therapeutics
|
May 11, 2023
Reasons Influencing Long-Term Anticoagulant Treatment Beyond 6 Months for Cancer-Associated Thrombosis in USCAT, A 432-Patient Retrospective Non-Interventional Study
Ludovic Plaisance, Céline Chapelle, Silvy Laporte, et al.
Page
of 14